The Role of Fecal M2-Pyruvate Kinase (M2-PK) in Colorectal Cancer Screening

Authors

  • Nur Chandra Bunawan Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
  • Marcellus Simadibrata Division of Gastroenterology, Department of Internal Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta

DOI:

https://doi.org/10.24871/181201738-42

Keywords:

M2-pyruvate kinase, M2-PK, fecal, colorectal cancer, screening

Abstract

Colorectal cancer is a malignancy with high incidence and mortality rate. The long carsinogenesis sequence from adenoma unto carsinoma enable early detection and screening as part of the management but until recently the commercialy available test has low sensitivity and specificity. M2-pyruvate kinase (M2-PK), an isomer of glycolisis enzyme involved in aerobic metabolism, is found in high amount in cancerous cell and is shed unto luminal mucosa in colorectal cancer. Quantification of this protein in feces is a promising method to detect malignant lesion of colon. Several studies until recently demonstrate moderate sensitivity and specificity but clearly with better performance than commonly-used gFOBT.

Published

2017-07-14

How to Cite

Bunawan, N. C., & Simadibrata, M. (2017). The Role of Fecal M2-Pyruvate Kinase (M2-PK) in Colorectal Cancer Screening. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 18(1), 38–42. https://doi.org/10.24871/181201738-42